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Ethanolic crude extractAmmocharis coranica (Ker-Gawl.) Herb. (Amaryllidaceae) is used in southern Africa for the treatment of mental
illnesses. The ethanol extracts of the bulb of A. coranica and its total alkaloids rich fractions were screened for in-
hibition of acetylcholinesterase enzyme (AChE), which is implicated in the pathophysiology of Alzheimer's dis-
ease. The ethanolic extracts signiﬁcantly inhibited AChE with IC50 value of 14.3±0.50 μg/ml. The basic ethyl
acetate and butanol fractions of the crude extracts were the most active against AChE with IC50 values of
43.1±1.22 and 0.05±0.02 μg/ml respectively. Bioassay-guided fractionation of the basic fractions led to the iso-
lation of lycorine and 24-methylenecycloartan-3β-ol. Lycorine which was isolated from both butanol and ethyl
acetate fractions had IC50 of 29.3±3.15 μg/ml, while 24-methylenecycloartan-3β-ol was not active.
© 2012 SAAB. Published by Elsevier B.V. All rights reserved.1. Introduction
Alzheimer's disease (AD) is a progressive neurodegenerative disor-
der characterised by dementia, behavioural abnormalities and death.
It is the leading cause of dementia in elderly people and with the
proportion of elderly people in the population increasing steadily, the
burden of the disease, both to caregivers and national economies, is
expected to become substantially greater over the next 2 to 3 decades
(Francis et al., 1999; Maslow, 2008).
The brain regions associated with higher mental functions, such as
the neocortex and hippocampus, aremostly affected by the characteris-
tic pathology of AD (Cummings, 2004). These abnormal pathologic fea-
tures include, extracellular deposits of β-amyloid derived from amyloid
precursor protein (APP) in senile plaques, intracellular formation of
neuroﬁbrillary tangles containing hyperphosphorylated form of a mi-
crotubule associated protein, tau and the loss of neuronal synapses
and pyramidal neurons, aswell as a decrease in levels of the neurotrans-
mitter acetylcholine (ACh) by nearly 90% (Cummings, 2004). These
changes result in the development of the typical symptoms of AD
characterised by gross and progressive damage of cognitive function,
often accompanied by behavioural disturbances such as memory loss,27 5298304.
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difﬁcult to copewith, and often lead to the hospitalisation of the patient
(Esiri, 1996).
The “cholinergic hypothesis of AD” was postulated on the basis of
the negative cognitive effect of cholinergic antagonists and the posi-
tive effect of muscarinic agonists on memory in humans (Guillou et
al., 2000), and became the neurobiological incentive for a treatment
aiming at the improvement of cholinergic function in AD. Inhibitors
of acetylcholinesterase (AChE), the enzyme involved in the metabolic
hydrolysis of acetylcholine (ACh) at cholinergic synapses, promote
increase in the concentration and duration of action of synaptic ACh
(Rollinger et al., 2004), thus serving as treatment strategy for AD, se-
nile dementia, ataxia, myasthenia gravis and Parkinson's disease
(Houghton et al., 2006). Acetylcholinesterase (AChE) inhibitors from
general chemical classes such as galanthamine, an Amaryllidaceae al-
kaloid isolated from the plant Galanthus woronowii (Heinrich and
Teoh, 2004) and other ACHE inhibitors have been used for the symp-
tomatic treatment of AD (Cummings, 2004). The non-selectivity of
these drugs, their limited efﬁcacy, and poor bioavailability, adverse
cholinergic side effects in the periphery, such as nausea, vomiting, di-
arrhoea, dizziness, and hepatotoxicity are among the several limita-
tions to their therapeutic success (Burns and Iliffe, 2009) hence the
continuous search for better AChE inhibitors from natural sources in-
cluding plants (Hostettmann et al., 2006; Houghton et al., 2006).
Ammocharis coranica (Ker-Gawl.) Herb., Amaryllidaceae, is a bulbous
plant widely distributed in the summer-rainfall regions of southern.
Table 1
Acetylcholinesterase inhibitory activity of the ethanolic crude extracts, butanol, ethyl
acetate fractions and lycorine isolated from the bulbs of Ammocharis coranica, expressed
as IC50.
Sample IC50 (μg/ml)a
Ethanolic crude extract 14.3±0.50
Butanol fraction 0.05±0.02
Ethyl acetate fraction 43.1±1.22
Lycorine 29.3±3.15
Physostigmine (reference compound) 1.51
a Expressed as mean±standard error mean (SEM).
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are used as cure for certain conditions resulting from witchcraft and di-
abolic spells (Hulme, 1954) and a remedy for mental illnesses (Stafford
et al., 2008). Despite the extensive chemical investigation of A. coranica
(Koorbanally et al., 2000; Mason et al., 1955) there is no report on the
effect of the bulbs of A. coranica on AChE activity. This project aimed at
screening the ethanolic crude extracts of the bulb of A. coranica and
their fractions for AChE inhibitory activity using TLC bioautographic
and microplate assays and isolating the bioactive compounds there
from.
2. Materials and methods
2.1. Plant material
The bulbs of A. coranica were collected from Bethelsdorp in the
Eastern Cape region of South Africa and authenticated by Mr Graham
Duncan. A voucher specimen, No. 39/69 was kept in the herbarium
of the Kirstenbosch National Botanical Garden. The collected plant
material was dried in an oven at 40 °C for several days and powdered
before extraction.
2.2. Extraction and bioassay guided fractionation
The dried, powdered plant materials (210 g) were extracted using
96% ethanol (2×2 l) by shaking for 48 h. The supernatant was ﬁltered
using Whatman No. 1 ﬁlter paper and concentrated to dryness under
reduced pressure to yield 16 g of crude extract. The crude extract was
treated with 6% acetic acid (300 ml) and then basiﬁed with ammonia
to pH 9.5, after removal of acidic and neutral material with dichlo-
romethane (200 ml×3). The basiﬁed solution was extracted with
ethyl acetate and butanol (200 ml×3) respectively and the organic
phases evaporated to dryness.
The ethyl acetate fraction (2.08 g) was subjected to column chro-
matography (20×5 cm) on silica gel 60 (200 g, Merck), eluted with
100% dichloromethane enriched gradually with 10% methanol up to
100% methanol. Nine fractions (A–I) were collected based on UV ab-
sorption, Dragendorff's test and AChE bioautographic assays. Fraction
E (tubes 68–78) was dissolved in dichloromethane:methanol (1:1)
and allowed to crystallise at room temperature to give compound 1.
Sub-fraction C (tubes 19–35) was dissolved in dichloromethane:
methanol (1:1). This was then applied on a preparative TLC plate
and eluted in hexane:ethyl acetate (2:1). The target compound was
scraped off the plate and the silica gel eluted with dichloromethane
to give compound 2.
The butanol fraction was subjected to column chromatography
(10×5 cm) on 100 g silica gel 60 (Merck) eluted with 100% dichlo-
romethane and then with dichloromethane enriched gradually with
20% methanol up to 100% methanol. Fractions 7–11 were combined
and allowed to crystallise and give more of compound 1.
2.3. Acetylcholinesterase enzyme inhibitory assay
2.3.1. Microtitre plate assay for acetylcholinesterase inhibition
Inhibition of acetylcholinesterase by the crude extract and, acid–
base fractions and the isolated compounds was determined using the
microplate assay (Rhee et al., 2001). Acetylcholinesterase (AChE) from
electric eel (type VI-s, lyophilised powder), the substrate, Acetylthio-
choline iodide (ACTI), Ellman's reagent, 5.5′-Dithiobis-(2-nitrobenzoic
acid) (DTNB) and Physostigmine, the reference compound were pur-
chased from Sigma (South Africa). The following buffers were used,
Buffer A: 50 mM Tris–HCl, pH 8; buffer B: 50 mM Tris–HCl, pH 8,
containing 0.1% bovine serum albumin (BSA); buffer C: 50 mM Tris–
HCl, pH8, containing 0.1 MNaCl and 0.02 MMgCl2.6H2O (ATCI) in buff-
er A and 15 mM in Millipore water were used for TLC bioautographic
and microplate assay respectively. For the TLC bioautographic assay,1 mM of DTNB in buffer A was used, while 3 mM DTNB was used for
the microplate assay. In the 96 well plates, 25 μl of 15 mM ATCI in
water, 125 μl DTNB (3 mM) in buffer C, 50 μl buffer B and 25 μl of seri-
ally diluted samples (two-fold for extracts, ten-fold for pure compounds
and Physostigmine)were added and the absorbancewasmeasured, in a
microplate reader, at 405 nm every 30 s three times, at 30 °C. Finally,
25 μl of 0.2 U/ml of enzyme solution was added in and the absorbance
was measured again after 3, 5, and 10 min respectively. The assays
were conducted in triplicate. Any increase in absorbance due to the
spontaneous hydrolysis of the substrate was corrected by subtracting
the average absorbance before adding the enzyme from the absorbance
after adding the enzyme. The percentage inhibition was calculated by
comparing the inhibition of the sample to the blank (10% methanol in
buffer A). The inhibitory concentration of 50% of AChE (IC50) value
was calculated from at least four different concentrations of the sample
using the Microsoft Excel statistical package.
2.3.2. Bioautographic assay for acetylcholinesterase inhibition
The TLC bioautographic assay was carried out as adopted from
Rhee et al. (2001). The dried crude extract of the bulbs of A. coranica
was dissolved in methanol (MeOH) to a concentration of 10 mg/ml,
of which 3 μl was spotted on TLC plate (Silica gel 60 F254, Merck)
and developed using chloroform:methanol (4:1) as the eluent. Physo-
stigmine (3 μl of 0.01 M) was used as a positive control. Thereafter,
enzyme inhibiting activity of the samples was detected by spraying
a mixture of the substrate (1 mM ATCI) and the dye (1 mM DTNB)
until the silica was saturatedwith the solution. The plateswere allowed
to dry for 3–5 min, before 3 units/ml enzyme solutions were sprayed
on the plates. A yellow background appeared, while white spots for
inhibiting compounds became visible after 5 min. The TLC plates were
scanned or photographed within 15 min before the reaction colour
disappeared.
2.3.3. Test for false positive results in the bioautographic method
The false positive reactions were eliminated using a method de-
veloped by Rhee et al. (2003). The TLC plate was prepared as de-
scribed above and sprayed with 1 mM DTNB in buffer A. The plate
was allowed to dry (3–5 min) and then sprayed with thiocholine,
the product formed when 1 mM ATCI in 3 units/ml enzyme stock so-
lution was incubated at 37 °C for 20 min. The appearance of a yellow
background or white spot was scanned or photographed and saved.
3. Results and discussions
Table 1 shows the IC50 values for AChE inhibitory activity of the eth-
anol extracts of A. coranica, the different fractions obtained using acid–
base fractionation and the isolated compounds there from. The ethanol
crude extracts of A. coranica had an IC50 value of 14.3±0.50 μg/ml.
However, butanol and ethyl acetate fractions had the highest AChE
inhibitory effect among the fractions tested with IC50 values of 0.05±
0.02 and 43.1±1.22 μg/ml respectively, which had been chosen for
the isolation of compounds with AChE inhibitory activity. A number of
Amaryllidaceae species have also shown AChE inhibitory activity in-
cluding Narcissus species (Coelho and Birks, 2001), Crinum macowanii,
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bowdenii (Jäger et al, 2004; Rhee et al., 2003; Risa et al., 2004).
Bioassay-guided fractionation of the butanol and ethyl acetate
fractions led to the isolation of two compounds lycorine (Fig. 1) and
24-methylenecycloartan-3β-ol (Fig. 1). The 1H NMR (DMSO-d6) spec-
tra of lycorine revealed peaks of H-8, H-11 at 6.79, 6.66, signal of a
methylenedioxy group (CH2-12) at 5.94, signals of H-1, H-2, and H-3
appear at 4.90, 4.26 and 5.35 respectively; in addition to the signals of
three methylene groups of H-4, H-5, and H-7 between 4.00 and 2.20.
The 13C NMR (DMSO-d6) exhibited 16 carbons, four of them were
methylene groups at 100.6, 56.7, 53.3 and 28.1 of C-12, C-7, C-5, C-4
and seven methane groups at 118.5, 107.1, 105.1, 71.7, 70.2, 60.8
and 40.2 of C-3, C-8, C-11c and C-11b data are in agreementwith previ-
ously published data for lycorine (Evidente et al., 1983; Schultz et
al., 1996; Toriizuka et al., 2008) and 24-methylenecycloartan-3β-ol
(Koorbanally et al., 2000; Mesquita et al., 2008; Teresa et al., 1987).
The NMR (CDCl3) data of 24-methylenecycloartan-3β-ol revealed in
the 1H NMR spectra signals assigned to H-3 proton at 3.19, two proton
singlet of CH2-28 at 4.69, 4.64, high ﬁeld signals at 0.13, 0.36 of CH2-19,
in addition to unresolved sevenmethyl group signals around 1.00 ppm.
The 13C NMR data conﬁrmed the presence of the terminal double bond
at 157.3, 106.3, and the hydroxylated C-3 at 76.5. The remaining data
could not be resolved due to the compactness of the spectra.
Lycorine is the most widely distributed alkaloid in the family
Amaryllidaceae and has been isolated from almost every member of
the family including A. coranica (Koorbanally et al., 2000). Lycorine
also had a wide range of biological activities including antifungal
(Evidente et al., 2004), antiviral (Ieven et al, 1982), antimalarial
(Campbell et al., 1998) activities and toxic effects both in vitro and
in vivo (Likhitwitayawuid et al., 1993; Lin et al., 1995; Liu et al., 2007).
In our experiment the IC50 of lycorine was 29.4±3.15 μg/ml (102±
7.8 μM). Lycorine isolated from other Amaryllidaceae plants has also
been tested for AChE inhibitory activity. Elgorashi et al. (2004) foundN
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Fig. 1. The chemical structure of lycorine 1 and 24-methylenecycloartan-3B-ol 2.that the IC50 of lycorine isolated from C. macowanii was 213 μM while
Houghton et al. (2004) established an IC50 of 450 μM, for lycorine
isolated Crinum jagus and Crinum glaucum from south-western part of
Nigeria. According to López et al. (2002) and McNulty et al. (2010)
lycorine was not active, however, McNulty and co-workers tested the
alkaloid at a maximum concentration of 10 μM which is not expected
to exhibit any activity while information on the concentration used by
López et al. (2002) is lacking. The discrepancies in the IC50 of lycorine
are obvious and could be attributed to differences in the method and
conditions adopted in the independent experiments, and the poor solu-
bility of lycorine inmost organic solvents includingmethanol. Although
the calculated values of the three independent IC50 of lycorine varied,
the most consistent deduction from the three experiments is that
lycorine has appreciable inhibitory activity against AChE. In our experi-
ment physostigmine (positive control) is about 68 times a stronger in-
hibitor of AChE than lycorine. The fact that lycorine is toxic (Ghosal et
al., 1985; Lin et al., 1995) and has weak inhibitory effect on AChE
(Elgorashi et al., 2004; Houghton et al., 2004) makes it a less suitable
candidate for the development of an AD drug.
The second compound, 24-methylenecycloartan-3β-ol, has been
isolated previously from A. coranica (Koorbanally et al., 2000). The
compound did not exhibit acetylcholinesterase inhibitory activity.
The negative values indicate that the compound had no inhibitory ac-
tivity against AChE at the concentration used in the microplate assay,
although it showed zone of inhibition when screened using the thin
layer chromatography bioautographic assay. This is however, the
ﬁrst report of the test of this compound for AChE inhibitory activity.
Lycorine is the only alkaloid isolated in this study from the most
active butanol fraction of A. coranica. Previous studies, however,
highlighted the presence of the alkaloids lycorine, caranine, acetyl-
caranine, crinamine, hippadine, 6α-hydroxypowelline, 1-O-acetyl-
9-O-demethylpluviine, buphandrine, ambelline, epivittatine and
1-O-acetyllycorine in extracts from A. coranica (Koorbanally et al.,
2000; Mason et al., 1955). Given the low ACHE inhibitory activity
of lycorine, it is possible that the potency of the butanol fraction
may have resulted from some these alkaloids, especially 1-O-
acetyllycorine, one of the most potent ACHE inhibitors.
In conclusion, the ethanolic crude extract of the bulbs of A.
coranica like other members of the Amaryllidaceae family showed
AChE inhibitory activity. The preliminary thin layer chromatography
bioautographic assay investigation of the ethanolic crude extract of
the bulbs of A. coranica showed several white spots of inhibition, con-
ﬁrmed not to be false positives. Lycorine is again established to inhibit
acetylcholinesterase, while 24-methylenecycloartan-3β-ol is not ac-
tive. The high acetylcholinesterase inhibitory activity of the butanol
fraction could be attributed to the synergistic action of its constitu-
ents and more research should be carried out on this fraction due to
the promising acetylcholinesterase inhibitory activity.
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